Lorenz Kevin 4
4 · Fortress Biotech, Inc. · Filed Apr 9, 2021
Insider Transaction Report
Form 4
Lorenz Kevin
Director
Transactions
- Purchase
COMMON STOCK, PAR VALUE $0.001
2021-01-01+50,000→ 214,582 total
Footnotes (1)
- [F1]One-third of the shares will vest on each of January 1, 2022, 2023 and 2024, subject to continued service.